LB Pharmaceuticals Inc
LBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001691082
No open-market purchases or sales by LB Pharmaceuticals Inc insiders were filed in the last 90 days; 114 institutions reported holding it in 13F filings for Q2 2026, worth $965.9M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in LB Pharmaceuticals Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- +53 vs. Q2 2025
- Shares held
- 19.9M
- +19.9M vs. Q2 2025
- Total value
- $314.9M
- +$314.9M vs. Q2 2025
- New holders
- 53
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $965.9M |
| Q1 2026 | 77 | $692.4M |
| Q4 2025 | 68 | $551.8M |
| Q3 2025 | 53 | $314.9M |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding LB Pharmaceuticals Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Quarry LP | 11 | $174 | 0.00% | +11 | New |
| Wells Fargo & Company | 1,000 | $15.8K | 0.00% | +1,000 | New |
| UBS Group AG | 1,055 | $16.7K | 0.00% | +1,055 | New |
| Bank of America Corp | 1,700 | $26.8K | 0.00% | +1,700 | New |
| Federated Hermes, Inc. | 9,000 | $142.1K | 0.00% | +9,000 | New |
| Morgan Stanley | 9,605 | $151.7K | 0.00% | +9,605 | New |
| Landscape Capital Management, L.L.C. | 10,638 | $168.0K | 0.01% | +10,638 | New |
| XTX Topco Ltd | 11,276 | $178.0K | 0.01% | +11,276 | New |
| Jefferies Financial Group Inc. | 13,100 | $206.8K | 0.00% | +13,100 | New |
| Brevan Howard Capital Management LP | 13,259 | $209.4K | 0.00% | +13,259 | New |
| Two Sigma Investments, LP | 13,500 | $213.2K | 0.00% | +13,500 | New |
| Geode Capital Management, LLC | 13,591 | $214.6K | 0.00% | +13,591 | New |
| Quantessence Capital LLC | 14,225 | $224.6K | 0.07% | +14,225 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 14,535 | $229.5K | 0.04% | +14,535 | New |
| Aristeia Capital LLC | 15,270 | $241.1K | 0.01% | +15,270 | New |
| Manufacturers Life Insurance Company, The | 17,488 | $276.1K | 0.00% | +17,488 | New |
| Oxford Asset Management LLP | 17,763 | $280.5K | 0.09% | +17,763 | New |
| Squarepoint Ops LLC | 20,825 | $328.8K | 0.00% | +20,825 | New |
| Hudson Bay Capital Management LP | 27,097 | $427.9K | 0.00% | +27,097 | New |
| Acuta Capital Partners, LLC | 30,000 | $473.7K | 0.49% | +30,000 | New |
| Jane Street Group, LLC | 30,345 | $479.1K | 0.00% | +30,345 | New |
| Barclays PLC | 30,839 | $486.9K | 0.00% | +30,839 | New |
| Point72 (DIFC) Ltd | 34,003 | $536.9K | 0.04% | +34,003 | New |
| TD Asset Management Inc | 36,780 | $580.8K | 0.00% | +36,780 | New |
| Monashee Investment Management LLC | 40,000 | $631.6K | 0.31% | +40,000 | New |
| HRT Financial LP | 58,815 | $928.0K | 0.00% | +58,815 | New |
| Silverarc Capital Management, LLC | 70,000 | $1.11M | 0.16% | +70,000 | New |
| Boxer Capital Management, LLC | 70,000 | $1.11M | 0.35% | +70,000 | New |
| Ameriprise Financial Inc | 77,450 | $1.22M | 0.00% | +77,450 | New |
| Integral Health Asset Management, LLC | 100,000 | $1.58M | 0.12% | +100,000 | New |
| Adage Capital Partners GP, L.L.C. | 200,000 | $3.16M | 0.01% | +200,000 | New |
| Baker Bros. Advisors LP | 200,000 | $3.16M | 0.02% | +200,000 | New |
| Marshall Wace, LLP | 255,526 | $4.03M | 0.00% | +255,526 | New |
| Price T Rowe Associates Inc | 282,644 | $4.46M | 0.00% | +282,644 | New |
| Nan Fung Group Holdings Ltd | 300,000 | $4.74M | 7.95% | +300,000 | New |
| Goldman Sachs Group Inc | 343,523 | $5.42M | 0.00% | +343,523 | New |
| Wellington Management Group LLP | 344,657 | $5.44M | 0.00% | +344,657 | New |
| FMR LLC | 369,100 | $5.83M | 0.00% | +369,100 | New |
| Soleus Capital Management, L.P. | 400,000 | $6.32M | 0.34% | +400,000 | New |
| Millennium Management LLC | 538,169 | $8.50M | 0.01% | +538,169 | New |
| Citadel Advisors LLC | 539,370 | $8.52M | 0.01% | +539,370 | New |
| Alyeska Investment Group, L.P. | 675,000 | $10.7M | 0.03% | +675,000 | New |
| Nantahala Capital Management, LLC | 675,000 | $10.7M | 0.66% | +675,000 | New |
| Jennison Associates LLC | 739,040 | $11.7M | 0.01% | +739,040 | New |
| Vivo Capital, LLC | 800,000 | $12.6M | 1.02% | +800,000 | New |
| Balyasny Asset Management LLC | 968,274 | $15.3M | 0.03% | +968,274 | New |
| BlackRock, Inc. | 975,000 | $15.4M | 0.00% | +975,000 | New |
| JPMorgan Chase & Co | 1,032,603 | $16.3M | 0.00% | +1,032,603 | New |
| Logos Global Management LP | 1,130,000 | $17.8M | 1.76% | +1,130,000 | New |
| Commodore Capital LP | 1,500,000 | $23.7M | 1.16% | +1,500,000 | New |
| TCG Crossover Management, LLC | 1,745,016 | $27.6M | 1.36% | +1,745,016 | New |
| Ra Capital Management, L.P. | 1,776,958 | $28.1M | 0.35% | +1,776,958 | New |
| Deep Track Capital, LP | 3,352,804 | $52.9M | 1.48% | +3,352,804 | New |